Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1900 participants.
Also called NCT02617290
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,900 participants
- Registry
-
NCT02617290
-
- Other papers using this trial's data
- Definition and Prediction of Periprocedural Myocardial Infarction in Elective Percutaneous Coronary Intervention: The ALPHEUS-MI Study
- Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study
- Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02617290. Randomized; no masking; primary purpose treatment. Start 2017-01-09 (actual); primary completion 2020-05-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
- Acronym
- ALPHEUS
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Ischemia
- Condition
- Myocardial Infarction
- Condition
- Stent Thrombosis
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Collaborator
- Action Research Group
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct02617290- Content hash
b007b51e7847c802460dced78a3508717cc3ffff68b86ea50a4f95ec82303898